Table 2.

Serum Phospholipids in Lean and Obese Patients and Patients With PCOS

LCOBLPOP
PA, pmol/mL2016.9 ± 345.63864.2 ± 1558.51938.3 ± 360.23314.9 ± 829.1
Phosphatidylglycerol, pmol/mL1813.3 ± 445.93252.3 ± 856.5390.7 ± 72.8d2038.8 ± 615.1
PI, pmol/mL3068.3 ± 492.84099.4 ± 780.11510.3 ± 276.9c3399.3 ± 803.5
PS, pmol/mL3211.2 ± 1519.91,3573.7 ± 6010.81183.3 ± 327.31,2974.2 ± 8466.0
Cer, pmol/mL2375.8 ± 172.53154.1 ± 116.9a3860.7 ± 297.6b,c3105.2 ± 219.5a,e
LPC, nmol/mL497.2 ± 66.0355.9 ± 32.1382.3 ± 80.7314.2 ± 51.6a
PC, nmol/mL619.3 ± 54.8761.7 ± 44.9792.0 ± 97.6856.9 ± 59.2a
PC:D16:0–18:2176.1 ± 17.3203.9 ± 10.2236.0 ± 39.4249.9 ± 18.3a
PC:D18:2–18:2/D16:0–20:478.7 ± 8.6107.1 ± 9.395.2 ± 23.3107.2 ± 9.6
PC:D18:2–20:2/D18:0–20:450.4 ± 4.071.5 ± 6.6a58.5 ± 8.066.6 ± 5.4a
PC:D18:1–18:2/D16:0–20:339.1 ± 5.244.7 ± 8.656.3 ± 6.958.2 ± 7.0a
PC:D18:0–18:2/D18:1–18:188.1 ± 9.298.2 ± 11.3117.8 ± 11.6127.7 ± 13.3a
LPC:16:0133.2 ± 21.8124.9 ± 21.776.3 ± 17.2a85.7 ± 11.2a
LPC:P18:115.1 ± 4.84.8 ± 1.5a10.8 ± 3.24.7 ± 0.98a
LPC: P18:019.2 ± 7.09.2 ± 2.612.5 ± 2.97.4 ± 2.4a
LPC:18:134.4 ± 5.724.6 ± 2.040.7 ± 11.220.2 ± 2.0a,e
LPC:18:053.8 ± 7.551.2 ± 7.148.8 ± 14.542.8 ± 8.1
LCOBLPOP
PA, pmol/mL2016.9 ± 345.63864.2 ± 1558.51938.3 ± 360.23314.9 ± 829.1
Phosphatidylglycerol, pmol/mL1813.3 ± 445.93252.3 ± 856.5390.7 ± 72.8d2038.8 ± 615.1
PI, pmol/mL3068.3 ± 492.84099.4 ± 780.11510.3 ± 276.9c3399.3 ± 803.5
PS, pmol/mL3211.2 ± 1519.91,3573.7 ± 6010.81183.3 ± 327.31,2974.2 ± 8466.0
Cer, pmol/mL2375.8 ± 172.53154.1 ± 116.9a3860.7 ± 297.6b,c3105.2 ± 219.5a,e
LPC, nmol/mL497.2 ± 66.0355.9 ± 32.1382.3 ± 80.7314.2 ± 51.6a
PC, nmol/mL619.3 ± 54.8761.7 ± 44.9792.0 ± 97.6856.9 ± 59.2a
PC:D16:0–18:2176.1 ± 17.3203.9 ± 10.2236.0 ± 39.4249.9 ± 18.3a
PC:D18:2–18:2/D16:0–20:478.7 ± 8.6107.1 ± 9.395.2 ± 23.3107.2 ± 9.6
PC:D18:2–20:2/D18:0–20:450.4 ± 4.071.5 ± 6.6a58.5 ± 8.066.6 ± 5.4a
PC:D18:1–18:2/D16:0–20:339.1 ± 5.244.7 ± 8.656.3 ± 6.958.2 ± 7.0a
PC:D18:0–18:2/D18:1–18:188.1 ± 9.298.2 ± 11.3117.8 ± 11.6127.7 ± 13.3a
LPC:16:0133.2 ± 21.8124.9 ± 21.776.3 ± 17.2a85.7 ± 11.2a
LPC:P18:115.1 ± 4.84.8 ± 1.5a10.8 ± 3.24.7 ± 0.98a
LPC: P18:019.2 ± 7.09.2 ± 2.612.5 ± 2.97.4 ± 2.4a
LPC:18:134.4 ± 5.724.6 ± 2.040.7 ± 11.220.2 ± 2.0a,e
LPC:18:053.8 ± 7.551.2 ± 7.148.8 ± 14.542.8 ± 8.1

Data are mean ± standard error of the mean.

Abbreviations: Cer, ceramide; PA, phosphatidic acid.

a

P < 0.05.

b

P < 0.01 compared with group LC.

c

P < 0.05.

d

P < 0.01 compared with group OB.

e

P < 0.05.

Table 2.

Serum Phospholipids in Lean and Obese Patients and Patients With PCOS

LCOBLPOP
PA, pmol/mL2016.9 ± 345.63864.2 ± 1558.51938.3 ± 360.23314.9 ± 829.1
Phosphatidylglycerol, pmol/mL1813.3 ± 445.93252.3 ± 856.5390.7 ± 72.8d2038.8 ± 615.1
PI, pmol/mL3068.3 ± 492.84099.4 ± 780.11510.3 ± 276.9c3399.3 ± 803.5
PS, pmol/mL3211.2 ± 1519.91,3573.7 ± 6010.81183.3 ± 327.31,2974.2 ± 8466.0
Cer, pmol/mL2375.8 ± 172.53154.1 ± 116.9a3860.7 ± 297.6b,c3105.2 ± 219.5a,e
LPC, nmol/mL497.2 ± 66.0355.9 ± 32.1382.3 ± 80.7314.2 ± 51.6a
PC, nmol/mL619.3 ± 54.8761.7 ± 44.9792.0 ± 97.6856.9 ± 59.2a
PC:D16:0–18:2176.1 ± 17.3203.9 ± 10.2236.0 ± 39.4249.9 ± 18.3a
PC:D18:2–18:2/D16:0–20:478.7 ± 8.6107.1 ± 9.395.2 ± 23.3107.2 ± 9.6
PC:D18:2–20:2/D18:0–20:450.4 ± 4.071.5 ± 6.6a58.5 ± 8.066.6 ± 5.4a
PC:D18:1–18:2/D16:0–20:339.1 ± 5.244.7 ± 8.656.3 ± 6.958.2 ± 7.0a
PC:D18:0–18:2/D18:1–18:188.1 ± 9.298.2 ± 11.3117.8 ± 11.6127.7 ± 13.3a
LPC:16:0133.2 ± 21.8124.9 ± 21.776.3 ± 17.2a85.7 ± 11.2a
LPC:P18:115.1 ± 4.84.8 ± 1.5a10.8 ± 3.24.7 ± 0.98a
LPC: P18:019.2 ± 7.09.2 ± 2.612.5 ± 2.97.4 ± 2.4a
LPC:18:134.4 ± 5.724.6 ± 2.040.7 ± 11.220.2 ± 2.0a,e
LPC:18:053.8 ± 7.551.2 ± 7.148.8 ± 14.542.8 ± 8.1
LCOBLPOP
PA, pmol/mL2016.9 ± 345.63864.2 ± 1558.51938.3 ± 360.23314.9 ± 829.1
Phosphatidylglycerol, pmol/mL1813.3 ± 445.93252.3 ± 856.5390.7 ± 72.8d2038.8 ± 615.1
PI, pmol/mL3068.3 ± 492.84099.4 ± 780.11510.3 ± 276.9c3399.3 ± 803.5
PS, pmol/mL3211.2 ± 1519.91,3573.7 ± 6010.81183.3 ± 327.31,2974.2 ± 8466.0
Cer, pmol/mL2375.8 ± 172.53154.1 ± 116.9a3860.7 ± 297.6b,c3105.2 ± 219.5a,e
LPC, nmol/mL497.2 ± 66.0355.9 ± 32.1382.3 ± 80.7314.2 ± 51.6a
PC, nmol/mL619.3 ± 54.8761.7 ± 44.9792.0 ± 97.6856.9 ± 59.2a
PC:D16:0–18:2176.1 ± 17.3203.9 ± 10.2236.0 ± 39.4249.9 ± 18.3a
PC:D18:2–18:2/D16:0–20:478.7 ± 8.6107.1 ± 9.395.2 ± 23.3107.2 ± 9.6
PC:D18:2–20:2/D18:0–20:450.4 ± 4.071.5 ± 6.6a58.5 ± 8.066.6 ± 5.4a
PC:D18:1–18:2/D16:0–20:339.1 ± 5.244.7 ± 8.656.3 ± 6.958.2 ± 7.0a
PC:D18:0–18:2/D18:1–18:188.1 ± 9.298.2 ± 11.3117.8 ± 11.6127.7 ± 13.3a
LPC:16:0133.2 ± 21.8124.9 ± 21.776.3 ± 17.2a85.7 ± 11.2a
LPC:P18:115.1 ± 4.84.8 ± 1.5a10.8 ± 3.24.7 ± 0.98a
LPC: P18:019.2 ± 7.09.2 ± 2.612.5 ± 2.97.4 ± 2.4a
LPC:18:134.4 ± 5.724.6 ± 2.040.7 ± 11.220.2 ± 2.0a,e
LPC:18:053.8 ± 7.551.2 ± 7.148.8 ± 14.542.8 ± 8.1

Data are mean ± standard error of the mean.

Abbreviations: Cer, ceramide; PA, phosphatidic acid.

a

P < 0.05.

b

P < 0.01 compared with group LC.

c

P < 0.05.

d

P < 0.01 compared with group OB.

e

P < 0.05.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close